# Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours

> **NCT02181075** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 10 (actual)

## Conditions studied

- Liver Tumour

## Interventions

- **DRUG:** ThermoDox® (LTLD)
- **DEVICE:** Focused Ultrasound of Target Liver Tumour
- **DIAGNOSTIC_TEST:** Pre-LTLD Biopsy of Target Liver Tumour
- **DIAGNOSTIC_TEST:** Post-LTLD Biopsy of Target Liver Tumour
- **DIAGNOSTIC_TEST:** Post-LTLD+FUS (Post-FUS) Biopsy of Target Liver Tumour
- **DEVICE:** Thermometry of Target Tumour

## Key facts

- **NCT ID:** NCT02181075
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2017-03
- **Final completion:** 2017-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2019-07-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02181075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02181075, "Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02181075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*